FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W57729908> ?p ?o ?g. }

• W57729908 endingPage "8" @default.
• W57729908 startingPage "643" @default.
• W57729908 abstract "To observe the expression of Toll-like receptor 8 (TLR8) in human cervical cancer cell-line HeLa cells, and the effects of TLR8 agonist CL075 on the survival and proliferation of HeLa cells.PCR and RT-PCR were used to detect the expression of TLR8 in 13 cancer cell lines, and the expression of COX-2, Bcl-2, VEGF mRNA in the HeLa cells stimulated by TLR8 agonist CL075 were also measured by RT-PCR. Immunofluorescence technique was used to determine the exact location of TLR8 in the cells. The percentage of viable cells was determined by trypan blue exclusion after the HeLa cells were stimulated with TLR8 agonist CL075 (0.1 µg/ml, 0.5 µg/ml, 1.0 µg/ml, 2.5 µg/ml), and cell cycle and apoptosis were analyzed by flow cytometry, and the proliferation was measured by MTT.Compared with the other cancer cell lines, the expression of TLR8 in HeLa cells was the highest (703.7 ± 20.6). After stimulation by CL075, the cells had a remarkable increase of the percentage of cells in G(2)/M + S phases. In the control group, the percentage of cells in G(2)/M +S phases was (39.02 ± 2.33)%, whereas after stimulated with 1.0 µg/ml CL075, the percentage of cells in G(2)/M + S phases reached the highest ratio (57.67 ± 1.73)%, and the percentage of cells in G(2)/M + S phases had a less decrease after 2.5 µg/ml CL075 stimulation and the percentage was (56.14 ± 3.73)%. After the CL075 treatment, there was no significant changes of apoptosis compared with that of the control cells (P > 0.05), but after DDP treatment the apoptosis had a significant change (P < 0.01). After stimulation by 1.0 µg/ml CL075 for 24 h, no significant difference (P > 0.05) was found by MTT test, but a significant difference was found at 48 h and 72 h (P < 0.01). An increased expression of COX-2, Bcl-2 and VEGF mRNA was observed in HeLa cells after stimulation by TLR8 agonist CL075 for 24 h and 48 h (P < 0.05).Expression of TLR8 is significantly increased in HeLa cells. The proportion of cells at different phases has a significant change after CL075 stimulation, which may up-regulate the proliferation of HeLa cells. These data suggested that TLR8 agonist may influence the tumor development and TLR8 may become a potential target in the treatment for cervical cancer." @default.
• W57729908 created "2016-06-24" @default.
• W57729908 creator A5000336592 @default.
• W57729908 creator A5013437001 @default.
• W57729908 creator A5021410423 @default.
• W57729908 creator A5027900862 @default.
• W57729908 creator A5032338349 @default.
• W57729908 creator A5041471791 @default.
• W57729908 creator A5044241067 @default.
• W57729908 creator A5060390157 @default.
• W57729908 creator A5065669986 @default.
• W57729908 creator A5090372136 @default.
• W57729908 date "2011-09-01" @default.
• W57729908 modified "2023-09-25" @default.
• W57729908 title "[Expression of TLR8 in human cervical cancer HeLa cells and the effect of TLR8 agonist on the cell proliferation and apoptosis]." @default.
• W57729908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22340042" @default.
• W57729908 hasPublicationYear "2011" @default.
• W57729908 type Work @default.
• W57729908 sameAs 57729908 @default.
• W57729908 citedByCount "0" @default.
• W57729908 crossrefType "journal-article" @default.
• W57729908 hasAuthorship W57729908A5000336592 @default.
• W57729908 hasAuthorship W57729908A5013437001 @default.
• W57729908 hasAuthorship W57729908A5021410423 @default.
• W57729908 hasAuthorship W57729908A5027900862 @default.
• W57729908 hasAuthorship W57729908A5032338349 @default.
• W57729908 hasAuthorship W57729908A5041471791 @default.
• W57729908 hasAuthorship W57729908A5044241067 @default.
• W57729908 hasAuthorship W57729908A5060390157 @default.
• W57729908 hasAuthorship W57729908A5065669986 @default.
• W57729908 hasAuthorship W57729908A5090372136 @default.
• W57729908 hasConcept C121608353 @default.
• W57729908 hasConcept C126322002 @default.
• W57729908 hasConcept C1491633281 @default.
• W57729908 hasConcept C153911025 @default.
• W57729908 hasConcept C16685009 @default.
• W57729908 hasConcept C170493617 @default.
• W57729908 hasConcept C185592680 @default.
• W57729908 hasConcept C190283241 @default.
• W57729908 hasConcept C2777366897 @default.
• W57729908 hasConcept C2778938600 @default.
• W57729908 hasConcept C2780070996 @default.
• W57729908 hasConcept C2780783641 @default.
• W57729908 hasConcept C29537977 @default.
• W57729908 hasConcept C54355233 @default.
• W57729908 hasConcept C553184892 @default.
• W57729908 hasConcept C55493867 @default.
• W57729908 hasConcept C62112901 @default.
• W57729908 hasConcept C71924100 @default.
• W57729908 hasConcept C81885089 @default.
• W57729908 hasConcept C86803240 @default.
• W57729908 hasConcept C96232424 @default.
• W57729908 hasConceptScore W57729908C121608353 @default.
• W57729908 hasConceptScore W57729908C126322002 @default.
• W57729908 hasConceptScore W57729908C1491633281 @default.
• W57729908 hasConceptScore W57729908C153911025 @default.
• W57729908 hasConceptScore W57729908C16685009 @default.
• W57729908 hasConceptScore W57729908C170493617 @default.
• W57729908 hasConceptScore W57729908C185592680 @default.
• W57729908 hasConceptScore W57729908C190283241 @default.
• W57729908 hasConceptScore W57729908C2777366897 @default.
• W57729908 hasConceptScore W57729908C2778938600 @default.
• W57729908 hasConceptScore W57729908C2780070996 @default.
• W57729908 hasConceptScore W57729908C2780783641 @default.
• W57729908 hasConceptScore W57729908C29537977 @default.
• W57729908 hasConceptScore W57729908C54355233 @default.
• W57729908 hasConceptScore W57729908C553184892 @default.
• W57729908 hasConceptScore W57729908C55493867 @default.
• W57729908 hasConceptScore W57729908C62112901 @default.
• W57729908 hasConceptScore W57729908C71924100 @default.
• W57729908 hasConceptScore W57729908C81885089 @default.
• W57729908 hasConceptScore W57729908C86803240 @default.
• W57729908 hasConceptScore W57729908C96232424 @default.
• W57729908 hasIssue "9" @default.
• W57729908 hasLocation W577299081 @default.
• W57729908 hasOpenAccess W57729908 @default.
• W57729908 hasPrimaryLocation W577299081 @default.
• W57729908 hasRelatedWork W123774176 @default.
• W57729908 hasRelatedWork W2352284239 @default.
• W57729908 hasRelatedWork W2363671651 @default.
• W57729908 hasRelatedWork W2364535361 @default.
• W57729908 hasRelatedWork W2367968865 @default.
• W57729908 hasRelatedWork W2378203004 @default.
• W57729908 hasRelatedWork W2392114150 @default.
• W57729908 hasRelatedWork W2392484830 @default.
• W57729908 hasRelatedWork W2410520497 @default.
• W57729908 hasRelatedWork W3031579642 @default.
• W57729908 hasVolume "33" @default.
• W57729908 isParatext "false" @default.
• W57729908 isRetracted "false" @default.
• W57729908 magId "57729908" @default.
• W57729908 workType "article" @default.